Using publicly available data from The Cancer Genome Atlas database through the Tumor Immune Estimation Resource (33), we first investigated the effect of CD96 expression on the survival of patients with HPV+ or HPV– head and neck squamous cell carcinoma (HNSCC). Here, CD96 is linked to cancer.